Trial intelligence / Profile preview

HSC for Hair Growth in Androgenetic Alopecia

NCT01501617Phase 2Unknown

Sponsor
Histogen Inc.
Start
Dec 2011
Primary completion
Jun 2012
Countries
1
01

Overview

A Phase 2 trial of HST-001 in androgenetic alopecia (AGA), sponsored by Histogen Inc.. Status: unknown.

02

Drugs

HST-001
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on NCT01501617.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01501617.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call